Results for tag: "Hepatitis B Drug"

The Hepatitis B Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat the hepatitis B virus, a virus that can cause serious liver damage. These drugs are used to reduce the amount of virus in the body, reduce the risk of liver damage, and improve overall health. Common drugs used to treat hepatitis B include interferon, nucleoside analogues, and protease inhibitors. The Hepatitis B Drug market is highly competitive, with many companies offering treatments. Some of the major players in the market include Gilead Sciences, Merck & Co., AbbVie, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more